Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Nanchang UniversityActive in the last 2 years

Zhou Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8095-6920; OpenAlex author ID A5100382820. Sources: OpenAlex.

Their work

Papers
12 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2021: 1 paper · 2022: 3 papers · 2023: 3 papers · 2024: 1 paper · 2025: 3 papers · 2026: 1 paper

Papers 12

  1. Intratumoral microbiota promote pancreatic cancer progression via NaAc-mediated activation of the GPR43/AMPK/HADH pathway. Co-author DOI 10.1186/s12967-026-08231-w↗
  2. Targeting macrophage-directed pathological processes in pancreatic ductal adenocarcinoma: Mechanisms and targeted therapies. Co-author DOI 10.1016/j.cytogfr.2025.06.004↗
  3. Knockdown of PPP2R2B inhibits pancreatic cancer progression via the ERK/MAPK pathway by modulating EMT and apoptosis First author DOI 10.21203/rs.3.rs-5324510/v2↗
  4. Predictive value of geriatric nutritional risk index in patients with pancreatic cancer: a meta-analysis. Co-author DOI 10.3389/fnut.2025.1464447↗
  5. Long non-coding RNA MIR4435-2HG promotes pancreatic cancer progression by regulating ABHD17C through sponging miR-128-3p. Co-author DOI 10.21037/tcr-24-51↗
  6. A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer. Co-author DOI 10.1155/2023/3419401↗
  7. Comprehensive Analysis Identifies PKP3 Overexpression in Pancreatic Cancer Related to Unfavorable Prognosis. Co-author DOI 10.3390/biomedicines11092472↗
  8. Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis. Co-author DOI 10.3390/jpm13030409↗
  9. The microbiota and aging microenvironment in pancreatic cancer: Cell origin and fate. Co-author DOI 10.1016/j.bbcan.2022.188826↗
  10. Association of the Microbiota and Pancreatic Cancer: Opportunities and Limitations. Co-author DOI 10.3389/fimmu.2022.844401↗
  11. Challenges and Opportunities Associated With Platelets in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.850485↗
  12. Current understanding of ferroptosis in the progression and treatment of pancreatic cancer. Co-author DOI 10.1186/s12935-021-02166-6↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wence Zhou · 8 shared papers, 2021–2024 · strength 1.68
  2. Shi Dong · 5 shared papers, 2021–2024 · strength 1.02
  3. Huaqing Shi · 4 shared papers, 2022–2025 · strength 0.93
  4. Yan Du · 4 shared papers, 2022–2025 · strength 0.93
  5. Yunjiu Gou · 2 shared papers, 2025–2026 · strength 0.72
  6. Fangfang Han · 2 shared papers, 2022–2025 · strength 0.45
  7. Wenkai Jiang · 2 shared papers, 2023 · strength 0.44
  8. Ru He · 2 shared papers, 2022–2023 · strength 0.39
  9. Xin Li · 2 shared papers, 2021–2023 · strength 0.38
  10. Yaqi Hua · 1 shared paper, 2025 · strength 0.28
  11. Dongying Li · 1 shared paper, 2025 · strength 0.28
  12. Chunlu Dong · 1 shared paper, 2025 · strength 0.27
  13. Wence Zhou · 1 shared paper, 2025 · strength 0.27
  14. Ru He · 1 shared paper, 2024 · strength 0.26
  15. Hao Ming Xu · 1 shared paper, 2022 · strength 0.20
  16. Wenkai Jiang · 1 shared paper, 2021 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.